Literature DB >> 18769688

Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.

Eugene A Chu1, Julie M Wu, David E Tunkel, Stacey L Ishman.   

Abstract

Nasopharyngeal carcinoma (NPC) arises from the epithelium of the nasopharynx and is a rare tumor in most parts of the world, including the United States. Neck swelling, nasal obstruction, and epistaxis are the most common presenting symptoms. The etiology of NPC is multifactorial and includes genetic susceptibility, exposure to carcinogens, and prior infection with the Epstein-Barr virus (EBV). We report a case of a 16-year-old African-American male who presented with hemoptysis and a 3-month history of a neck mass. Diagnostic evaluation identified a nasopharyngeal mass that upon biopsy was shown to be an undifferentiated nasopharyngeal carcinoma with immunohistochemical stains markedly positive for EBV. Recent studies have further elucidated the role of EBV in the pathogenesis of NPC and have demonstrated the utility of EBV studies in staging, prognosis, and post-therapeutic monitoring.

Entities:  

Mesh:

Year:  2008        PMID: 18769688      PMCID: PMC2525461     

Source DB:  PubMed          Journal:  Medscape J Med        ISSN: 1934-1997


  11 in total

Review 1.  Optimal management of nasopharyngeal carcinoma.

Authors:  Sandrine Faivre; François Janot; Jean-Pierre Armand
Journal:  Curr Opin Oncol       Date:  2004-05       Impact factor: 3.645

Review 2.  Pathogenesis and treatment of nasopharyngeal carcinoma.

Authors:  Anthony T C Chan; Peter M L Teo; Dolly P Huang
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

3.  Nasopharyngeal carcinoma in the pediatric age group: the northern Israel (Rambam) medical center experience, 1989-2004.

Authors:  Motti Haimi; Myriam Weyl Ben Arush; Gil Bar-Sela; Eliahu Gez; Zvi Bernstein; Sergey Postovsky; Ayelet Ben Barak; Abraham Kuten
Journal:  J Pediatr Hematol Oncol       Date:  2005-10       Impact factor: 1.289

Review 4.  Epstein-Barr virus in the pathogenesis of NPC.

Authors:  Nancy Raab-Traub
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

5.  Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues.

Authors:  Liang Zhou; Weihong Jiang; Caiping Ren; Zhihua Yin; Xiangling Feng; Weidong Liu; Qian Tao; Kaitai Yao
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

Review 6.  Nonnasopharyngeal lymphoepitheliomas (undifferentiated carcinomas) of the upper aerodigestive tract.

Authors:  D K Frank; F Cheron; H Cho; D DiCostanzo; A P Sclafani
Journal:  Ann Otol Rhinol Laryngol       Date:  1995-04       Impact factor: 1.547

7.  The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition.

Authors:  K Shanmugaratnam; L H Sobin
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

8.  Cancer of the nasopharynx in children.

Authors:  M Deutsch; R Mercado; J A Parsons
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

9.  Nasopharyngeal cancer among young people in the United States: racial variations by cell type.

Authors:  M H Greene; J F Fraumeni; R Hoover
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

10.  Epidemiology of nasopharyngeal carcinoma.

Authors:  Mimi C Yu; Jian-Min Yuan
Journal:  Semin Cancer Biol       Date:  2002-12       Impact factor: 15.707

View more
  13 in total

1.  CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling.

Authors:  Stephanie N Hurwitz; Dingani Nkosi; Meghan M Conlon; Sara B York; Xia Liu; Deanna C Tremblay; David G Meckes
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

2.  Contribution of susceptibility locus at HLA class I region and environmental factors to occurrence of nasopharyngeal cancer in Northeast India.

Authors:  Meena Lakhanpal; Laishram Chandreshwor Singh; Tashnin Rahman; Jagnnath Sharma; M Madhumangal Singh; Amal Chandra Kataki; Saurabh Verma; Pradeep Singh Chauhan; Y Mohan Singh; Saima Wajid; Sujala Kapur; Sunita Saxena
Journal:  Tumour Biol       Date:  2014-12-17

3.  Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.

Authors:  Mark M Sasaki; Andrew D Skol; Riyue Bao; Lindsay V Rhodes; Rachelle Chambers; Everett E Vokes; Ezra E W Cohen; Kenan Onel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-05-26       Impact factor: 4.254

4.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

Review 5.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

6.  Long-Term Progression of Sensorineural Hearing Loss and Tinnitus after Combined Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma: A Case Report.

Authors:  Ming S Lee; Sudha Penumala; Steven Sweet; Russell R De Luca; Ariel E Stearnes; Yamac Akgun
Journal:  Case Rep Oncol       Date:  2017-08-09

Review 7.  Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.

Authors:  Shyam Singh; Hem Chandra Jha
Journal:  J Oncol       Date:  2017-03-21       Impact factor: 4.375

8.  Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.

Authors:  Hendrik Andreas Wolff; Ralph M W Rödel; Bastian Gunawan; Tobias Overbeck; Markus K A Herrmann; Steffen Hennies; Andrea Hille; Hilke Vorwerk; Christoph Matthias; Clemens F Hess; Hans Christiansen
Journal:  J Cancer Res Clin Oncol       Date:  2009-07-18       Impact factor: 4.553

9.  Trial watch: DNA vaccines for cancer therapy.

Authors:  Laura Senovilla; Erika Vacchelli; Pauline Garcia; Alexander Eggermont; Wolf Hervé Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

Review 10.  Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology.

Authors:  Ge Gao; David I Smith
Journal:  Viruses       Date:  2015-08-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.